Skip to content
Screener

Pulse Biosciences, Inc. PLSE Operating margin

Operating margin at other companies

Abbott logo
AbbottABT
15.8%-1.7pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
26.5%+2.8pp
Boston Scientific logo
Boston ScientificBSX
19.8%+2.8pp
AtriCure logo
AtriCureATRC
-5.1%-1.3pp
Medtronic logo
MedtronicMDT
17.8%0.0pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
12.2%+0.6pp

Other financials

Income statement

See full
Revenue$434.0K—
Gross profit$161.0K—
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+156%
Enterprise value$2.55B+173%
P/S2,233.4×—

Profitability

See full
Gross margin-0.1%—
Net margin-6,755.8%—
FCF margin-5,180.4%—

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

operating income/total revenue=-7,007.8%

Based on trailing twelve months.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288

FAQ

What is Pulse Biosciences, Inc.'s operating margin?
Pulse Biosciences, Inc. (PLSE) reported operating margin of -7,007.8% in Q2 2026.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Pulse Biosciences, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude